Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 5, 2006, Pages 1231.e1-1231.e11

  Engel, Stephanie M ^a   Olshan, Andrew F ^b,c   Siega Riz, Anna Maria ^b,c,d   Savitz, David A ^a,b,c   Chanock, Stephen J ^e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Epidemiology ^*

^c UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

^d University of North Carolina   (United States)

^e Division of Cancer Epidemiology and Genetics   (United States)

Author keywords

Intrauterine growth; MTHFR; MTR; MTRR; Polymorphism; Preterm birth; SHMT1; Small for gestational age

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE;

ADULT; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FOLATE METABOLISM; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; OUTCOME ASSESSMENT; PREMATURE LABOR; PRIORITY JOURNAL; RACE DIFFERENCE; SMALL FOR DATE INFANT;

EID: 33750973085     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.07.024     Document Type: Article

References (38)

1. Lievers K.J., Kluijtmans L.A., and Blom H.J. Genetics of hyperhomocysteinaemia in cardiovascular disease. Ann Clin Biochem 40 (2003) 46-59
2. Di Simone N., Maggiano N., Caliandro D., Riccardi P., Evangelista A., Carducci B., et al. Homocysteine induces trophoblast cell death with apoptotic features. Biol Reprod 69 (2003) 1129-1134
3. Ayar A., Celik H., Ozcelik O., and Kelestimur H. Homocysteine-induced enhancement of spontaneous contractions of myometrium isolated from pregnant women. Acta Obstet Gynecol Scand 82 (2003) 789-793
4. Jugessur A., Wilcox A.J., Lie R.T., Murray J.C., Taylor J.A., Ulvik A., et al. Exploring the effects of methylenetetrahydrofolate reductase gene variants C677T and A1298C on the risk of orofacial clefts in 261 Norwegian case-parent triads. Am J Epidemiol 157 (2003) 1083-1091
5. Christensen B., Arbour L., Tran P., Leclerc D., Sabbaghian N., Platt R., et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 84 (1999) 151-157
6. Richter B., Stegmann K., Roper B., Boddeker I., Ngo E.T., and Koch M.C. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J Hum Genet 46 (2001) 105-109
7. Keku T., Millikan R., Worley K., Winkel S., Eaton A., Biscocho L., et al. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 11 (2002) 1611-1621
8. Fang J.Y., and Xiao S.D. Folic acid, polymorphism of methyl-group metabolism genes, and DNA methylation in relation to GI carcinogenesis. J Gastroenterol 38 (2003) 821-829
9. Hishida A., Matsuo K., Hamajima N., Ito H., Ogura M., Kagami Y., et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 88 (2003) 159-166
10. Skibola C.F., Smith M.T., Hubbard A., Shane B., Roberts A.C., Law G.R., et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 99 (2002) 3786-3791
11. Savitz D.A., Dole N., Williams J., Thorp J.M., McDonald T., Carter A.C., et al. Determinants of participation in an epidemiological study of preterm delivery. Paediatr Perinat Epidemiol 13 (1999) 114-125
12. Zhang J., and Bowes Jr. W.A. Birth-weight-for-gestational-age patterns by race, sex, and parity in the United States population. Obstet Gynecol 86 (1995) 200-208
13. Packer B.R., Yeager M., Staats B., Welch R., Crenshaw A., Kiley M., et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res (2004) 32 Database issue:D528-32
14. Siega-Riz A.M., Savitz D.A., Zeisel S.H., Thorp J.M., and Herring A. Second trimester folate status and preterm birth. Am J Obstet Gynecol 191 (2004) 1851-1857
15. Dietsys Analysis Software: Block Dietary Data Systems.
16. Gregory III J.F. Case study: folate bioavailability. J Nutr 131 (2001) 1376S-1382S
17. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
18. Goyette P., Sumner J.S., Milos R., Duncan A.M., Rosenblatt D.S., Matthews R.G., et al. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 7 (1994) 551
19. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 (1998) 1044-1051
20. Weisberg I., Tran P., Christensen B., Sibani S., and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64 (1998) 169-172
21. Gebhardt G.S., Scholtz C.L., Hillermann R., and Odendaal H.J. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction. Eur J Obstet Gynecol Reprod Biol 97 (2001) 174-177
22. Infante-Rivard C., Rivard G.E., Yotov W.V., Genin E., Guiguet M., Weinberg C., et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 347 (2002) 19-25
23. Kupferminc M.J., Eldor A., Steinman N., Many A., Bar-Am A., Jaffa A., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340 (1999) 9-13
24. Martinelli P., Grandone E., Colaizzo D., Paladini D., Scianname N., Margaglione M., et al. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica 86 (2001) 428-431
25. Murphy R.P., Donoghue C., Nallen R.J., D'Mello M., Regan C., Whitehead A.S., et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 20 (2000) 266-270
26. Nurk E., Tell G.S., Refsum H., Ueland P.M., and Vollset S.E. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine Study. Am J Med 117 (2004) 26-31
27. Infante-Rivard C., Rivard G.E., Gauthier R., and Theoret Y. Unexpected relationship between plasma homocysteine and intrauterine growth restriction. Clin Chem 49 (2003) 1476-1482
28. Valdez L.L., Quintero A., Garcia E., Olivares N., Celis A., Rivas Jr. F., et al. Thrombophilic polymorphisms in preterm delivery. Blood Cells Mol Dis 33 (2004) 51-56
29. Gaughan D.J., Kluijtmans L.A., Barbaux S., McMaster D., Young I.S., Yarnell J.W., et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157 (2001) 451-456
30. Vaughn J.D., Bailey L.B., Shelnutt K.P., Dunwoody K.M., Maneval D.R., Davis S.R., et al. Methionine synthase reductase 66A->G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C->T variant. J Nutr 134 (2004) 2985-2990
31. Brown C.A., McKinney K.Q., Kaufman J.S., Gravel R.A., and Rozen R. A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease. J Cardiovasc Risk 7 (2000) 197-200
32. Bosco P., Gueant-Rodriguez R.M., Anello G., Barone C., Namour F., Caraci F., et al. Methionine synthase (MTR) 2756 (A → G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A 121 (2003) 219-224
33. Gueant-Rodriguez R.M., Rendeli C., Namour B., Venuti L., Romano A., Anello G., et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 344 (2003) 189-192
34. Heil S.G., Van der Put N.M., Waas E.T., den Heijer M., Trijbels F.J., and Blom H.J. Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?. Mol Genet Metab 73 (2001) 164-172
35. Daniel Jr. W.A., Mounger J.R., and Perkins J.C. Obstetric and fetal complications in folate-deficient adolescent girls. Am J Obstet Gynecol 111 (1971) 233-238
36. Scholl T.O., Hediger M.L., Schall J.I., Khoo C.S., and Fischer R.L. Dietary and serum folate: their influence on the outcome of pregnancy. Am J Clin Nutr 63 (1996) 520-525
37. Shaw G.M., Liberman R.F., Todoroff K., and Wasserman C.R. Low birth weight, preterm delivery, and periconceptional vitamin use. J Pediatr 130 (1997) 1013-1014
38. Hibbard B.M. Folates and the fetus. S Afr Med J 49 (1975) 1223-1226